In a study posted to the medRxiv* pre-print server, a team of researchers evaluated the performance of two different severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnostic assays, ...
The Molecular Diagnostic and Assay Development Hub is focused on expanding our targeted and agnostic diagnostic capabilities against viral threats with pandemic potential. During the two-year start-up ...
Advanced technologies are taking in vitro diagnostics (IVD) far beyond lateral flow tests or immunoassays. Molecular technologies like PCR and NGS are rapidly expanding in the diagnostic assay ...
The study has shown that a cancer diagnostic assay designed with Asian-centric biomarkers is safe and precise and can can measure 4 major classes of biomarkers, allowing for molecular characterisation ...
In a recent study posted to the medRxiv* preprint server, researchers analyzed the primer and probe sequences of the United States Centers for Disease Control and Prevention (CDC) recommended ...
Independent clinical validation strengthens ABL’s leadership in the fast‑growing HIV drug‑resistance testing market ABL ...
Next-generation, non-invasive diagnostic platform has potential applications in solid tumor types beyond liver cancerLicensing deal reflects ...
Infectious keratitis remains a leading cause of corneal blindness and visual impairment worldwide, with bacterial, fungal, ...
Leading Diagnostic Healthcare Company Also Announces Over 50 Initial Clinic Commitments for Its Full Diagnostic Assay Platform The Company had previously announced the commencement of commercial ...
This webinar examines practical approaches to strengthening lateral flow assay performance, with a focus on optimized sample ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results